Since the outbreak of COVID-19, clinical trials have become even more complex and competitive. In order to ensure success and meet patient enrollment targets, sponsors not only need to attract the best investigator sites, but also need to focus firmly on the patient through new ways of working, such as utilizing new routes and adjusting study protocols, including a rise in demand for direct-to-patient delivery.